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INTRODUCTION
The invasive Gram-negative pathogen Pseudo-
monas aeruginosa is a major cause of infection-re-
lated mortality among the critically ill patients (1)
and represents one of the most severe nosocomial
pathogens (1 - 4). The lungs are a major site of
P. aeruginosa infection among critically ill patients.
A significant number of such infections are caused
by direct contamination of the lungs by gastrointesti-
nal flora or by hematogenous dissemination from the
intestine to the lungs (1, 5, 6). The intestinal tract
is the most important reservoir for P. aeruginosa in
critically ill patients (7), and it has been demon-
strated that a major mechanism of the lethality of
intestinal P. aeruginosa lies in its ability to adhere
to and disrupt the intestinal epithelial barrier (8).
The surprising effect of statins, a class of drugs
generally prescribed for lowering cholesterol, on
the incidence and severity of bacteraemic sepsis
has been reported. Statins may have not only a pro-
tective effect against bacteraemic infections (9-11)
but also a beneficial effect on the incidence of bac-
teraemic sepsis and associated mortality in critically
ill patients (12) ; simvastatin inhibits Staphylococcus
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aureus host cell invasion (13). Taken together, these
findings strongly suggest that statin may modulate
the ability of P. aeruginosa to translocate across the
epithelial barrier.
In this study, we explored whether or not simvas-
tatin could modulate translocation by P. aeruginosa
through the epithelial barrier.
MATERIALS AND METHODS
Chemicals
Dimethylsulphoxide (DMSO) was purchased
from Kanto Chemical Co., Inc. (Tokyo). 3 - (4,5 -
Dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) was from Sigma Chemical Company
(St. Louis, MO). Dulbecco’s modified Eagle’s me-
dium (DMEM) and fetal bovine serum (FBS) were
from Wako Pure Chemical Industries Co. Ltd.
(Osaka) and Equi-Tech, Inc. (Salt Lake City, UT),
respectively. Triton X-100 was from Nacalai Tesque
Co. Ltd. (Kyoto). Mueller-Hinton broth and Tryp-
ticase Soy Agar were from Becton Dickinson and
Co. Japan (Tokyo).
Bacterial strain
P. aeruginosa PAO1 our laboratory stock strain
was used. The organisms were cultivated in Mueller-
Hinton broth at 37.
Cell line and culture
Madin-Darby canine kidney (MDCK) cells were
routinely passaged in DMEM supplemented with
10% heat-inactivated FBS and 100 μg/ml kanamycin.
For experimental assays, the cells were seeded at
a density of approximately 105 cells/cm2 in 24-well
tissue culture plates or on inserts (Chemotaxicell,
6.4 mm diameter, 3 μm pore size ; Kurabo Indus-
tries, Ltd., Osaka) that allow epithelial differentia-
tion between apical and basolateral compartments.
The cells were cultured at 37in 5% CO2-95% air
atmosphere and the medium was changed daily.
MDCK cells grown in 24-well tissue culture plates
were incubated to early confluence (undifferentiated
cells). MDCK cells grown on inserts were used at
days post-confluence (fully differentiated cells).
Measurement of bacterial growth
A fresh overnight culture of P. aeruginosa PAO1
at 37in MHB was diluted to 3105 cfu/ml with
sterile saline. Then, 10 μl dilutions were added into
1 ml DMEM containing DMSO solution of the drug
(final concentrations : 0.1% for DMSO and 5 μM for
the drug) or DMSO alone and incubated at 37.
At intervals, 100-μl aliquots were removed and di-
luted appropriately with sterile saline. Dilutions (100
μl) were spread onto Trypticase Soy Agar and cul-
tured overnight at 37. The colonies were then
counted.
Cell viability by MTT assay
Cell viability was determined by a colorimetric
assay using MTT (14). In the mitochondria of liv-
ing cells, yellow MTT undergoes a reductive con-
version to formazan, giving a purple color. Conflu-
ent MDCK cells in 96-well plates were treated with
simvastatin for 24 h. Then, the MTT solution (dis-
solved in phosphate buffer) was added (final con-
centration : 0.5 mg/ml) and the cells were further
incubated at 37for 1 h. After the culture medium
was removed, 200 μL acidified isopropanol was
added to dissolve the formazan formed by the re-
duction of MTT. The absorbance at 570 nm was
measured using a microplate reader. The percent
of growth for each treatment is calculated by com-
parison to that determined in control cultures.
MDCK cell monolayer penetration assay
The assay was performed as reported previously
(15, 16). In brief, MDCK cells in DMEM with 10%
FBS were seeded at 1.5105 cells per well in filter
units (Chemotaxicell). Monolayers were incubated
at 37in 5% CO2 for 4 d until the transmonolayer
electrical resistance (TER) reached the proper range
(900-1,200 Ωcm2), as measured with a Millicell-ESR
apparatus (Millipore, Billerica, MA). Monolayers
were infected with bacteria by adding 10 ml (3
106 cfu) freshly grown bacteria cultured in MHB
broth overnight at 37with shaking at 150 rpm.
In some experiments, TER was monitored at sev-
eral time intervals after infection to assess damage
to monolayers. The assay was performed in tripli-
cate. Each assay was repeated at least three times
to confirm reproducibility.
Bacterial invasion assay
With a slight modification, gentamicin survival
assays were performed to quantify the bacteria in-
vading MDCK cells (16, 17). After 1 h infection with
the bacteria (1105 cfu), monolayers were washed
three times with a phosphate-buffered saline and
then incubated a further 2 h in fresh medium con-
taining 20 μg/ml of gentamicin to kill extracellular
bacteria only. Monolayers were washed once with
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PBS and then lysed with a 0.25% Triton X-100 for
20 min. Appropriate dilutions were spread onto agar
plates, and incubated at 37overnight. Colony-
forming units were counted to quantify bacteria
surviving intracellularly.
Associated bacteria (including both adherent and
invading bacteria) were measured by the addition
of 1% Triton X-100 to the monolayers 3 h after in-
fection followed by six washes without gentamicin
treatment. As a control, filter units with medium
only and without MDCK cells were inoculated with
bacteria to determine baseline adherence to plastic.
The baseline values were subtracted from those
obtained by incubation with epithelial cells as de-
scribed above.
Statistical analysis
Data were expressed as median (interquartile
range) or meansignificant variance of the mean
(SD), as indicated. The general characteristics of
the two groups were tested by the Mann-Whitney
U test.
RESULTS AND DISCUSSION
The cytotoxic effect of simvastatin is shown in
Figure 1. The results demonstrated that at concen-
trations greater than 10 μM the drug was cytotoxic
against MDCK cells in a dose-dependent manner.
This means that its cytotoxicity to the MDCK cells
did not appear up to a concentration of 10 μM.
To clarify the effect of exposure of P. aeruginosa
PAO1 to simvastatin on the growth rate, the bacte-
ria were tested for their ability to grow in DMEM.
In our preliminary experiments, the number of bac-
teria hardly increased in the first 3 h of incubation,
and thereafter began to increase obviously. Hence,
the effect of simvastatin on bacterial growth was
evaluated at 1, 3 and 6 h of incubation in the pres-
ence of the drug at a concentration of 5 μM. Com-
pared with the result in the absence of the drug
(0.1% DMSO), the two assays showed great simi-
larities to each other in the pattern and extent of
the growth of bacteria. This indicated that the drug
at the concentration examined had no effect on the
growth of P. aeruginosa PAO1 (Figure 2).
P. aeruginosa PAO1 translocates across MDCK
monolayers (18). To confirm this, P. aeruginosa
PAO1 was quantified in the basolateral medium at
different times after apical infections of MDCK
monolayers. The bacteria were not detectable after
1 h of infection. After 3 h of infection, bacteria at a
population density of 4 log were detected in the ab-
sence of simvastatin (control), while the bacteria
detected in the basolateral compartment remained
Figure 1. Effect of simvastatin on MDCK cell viability. Con-
fluent MDCK cells in 96-well plates were treated with simvas-
tatin for 24 h. Then, the MTT assay was performed. The absor-
bance at 570 nm was measured using a microplate reader. The
percent of growth for each treatment is calculated by comparison
with that determined in control cultures. Each value represents
the meanS.D. (n=4).
Figure 2. Effect of simvastatin on the growth of P. aeruginosa
PAO1 in DMEM. Colony-forming units measured after 1 (open
column), 3 (striped column) and 6 h (diagonally striped column)
of growth in the absence (control) or presence of 5 μM simvas-
tatin. Data are the meanS.D. (n=3).
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at 3 log in the presence of the drug (Figure 3).
This result indicates that simvastatin repressed
the bacteria’s ability to translocate across MDCK
monolayers.
TER is a sensitive measure of tight junctional bar-
rier function and reflects the condition of tight junc-
tion formation. The TER values decreased as post-
infection time increased. However, there was no dif-
ference in the time courses of the decrease in TER
values between the presence and absence of simvas-
tatin (data not shown). The fall in TER was inde-
pendent of damages induced by acidification of the
medium, because the pH of the medium was held
constant during the experimental period. Based on
these results, it is likely that, although P. aeruginosa
PAO1 caused the great increase of paracellular per-
meability, simvastatin modulated the diminution of
bacterial activity.
It has been demonstrated that P. aeruginosa PAO1
can invade epithelial cells (17), suggesting that the
bacteria are able to invade MDCK cells, migrate
across the cytoplasm and egress at the level of the
basal membrane. This possible transcellular translo-
cation of P. aeruginosa PAO1 was investigated us-
ing a gentamicin survival assay in the presence or
absence of simvastatin. It is interesting to note that,
in both the presence and absence of simvastatin,
P. aeruginosa PAO1 at a population density of 4 log
was detected in the intracellular compartment of
MDCK cells (Figure 4). This observation clearly
demonstrates that the invasive behavior of bacteria
in MDCK cells was independent of the presence or
absence of simvastatin. Hence, it seems likely that
simvastatin exerted certain influences to protect
parts of the paracellular pathway of MDCK mono-
layers against damages caused by Pseudomonas
aeruginosa , thereby repressing the translocation of
bacteria, but not the flow of ions, from the apical to
the basolateral compartment.
As the epithelial barrier differentiates and be-
comes highly polarized, it becomes increasingly
resistant to P. aeruginosa infection (18). The integ-
rity of the epithelial cell monolayer is maintained by
junctional complexes composed of tight junctions,
adherens junctions and desmosomes. The tight junc-
tions are the most apical intercellular junctions. They
form a continuous belt-like structure at the luminal
Figure 3. Effect of simvastatin on the ability of P. aeruginosa
PAO1 to translocate across the MDCK cell monolayers. P. aerug-
inosa PAO1 was inoculated onto the apical surface of MDCK cell
monolayers. The bacteria translocated to the basolateral com-
partment were quantified after 3 h of infection. Results are ex-
pressed as the median and interquartile range of the number of
translocating bacteria counted after plating (cfu/ml). The two
groups were compared using analysis of variance repeated meas-
urements and least significant difference. P -value indicates the
significance of difference between the two groups. *P0.05 is
from the comparison of the two groups (Mann-Whitney U test).
Figure 4. Effect of simvastatin on the invasive ability of P.
aeruginosa PAO1 in MDCK cells. MDCK cells were infected for
1 h and intracellular bacteria were quantified by plating after gen-
tamicin had destroyed extracellular germs. Data are shown as
the median and interquartile range. Analysis of variance repeated
measurements and least significant difference revealed no sig-
nificant difference found between the groups.
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end of intercellular space that regulates the paracel-
lular flux (19). Some bacterial pathogens can ma-
nipulate the apical-junctional complex (20).
In the present study, simvastatin reduced bacte-
rial translocation across the MDCK monolayers in
the presence of simvastatin. Unfortunately, we failed
to demonstrate such an effect of simvastatin based
on the results of the TER measurement and the
gentamicin survival assay. A decrease in TER can
result from either an increase in paracellular per-
meability, local cell lysis in the monolayer or a
change in ion flux across the intact monolayer. It
is also known that the P. aeruginosa quorum-sens-
ing factor N-(3 oxodecanoyl)-L-homoserine lactone
can disrupt the epithelial barrier integrity (21). Ad-
ditionally, at present, there are a number of statins
available. Whether the findings shown in this study
are specific for simvastatin, or common with other
statins, remains to be clarified. Further studies are
needed to fully elucidate the role of simvastatin in
the translocation process of Pseudomonas aeruginosa
across the MDCK monolayers, and the results of
these experiments may help to understand the mo-
lecular mechanism used by the bacterium to modu-
late the intestinal epithelial barrier function.
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